Over the past year, Sano and BenevolentAI have collaborated to demonstrate how an integrated, decentralized platform — combining patient recruitment, at-home ge...
Continue reading
In a this webinar, Patrick Short, CEO and co-founder of Sano Genetics, and Patti Engel, CEO of Engage Health, discussed how applying a “rare disease mindset” ca...
Continue reading
Recruiting patients for clinical trials is a crucial component of the drug development process, and a key factor in determining the success or failure of a stud...
Continue reading
Earlier this month, our team had the pleasure of attending the CMO Summit 360 in Boston. This event brought together top-level medical executives and experts fr...
Continue reading
Precision medicine represents a fundamental shift in how therapies are developed and delivered. Rather than designing treatments for the average patient, it tak...
Continue reading
Patient retention remains one of the most persistent constraints in clinical trial execution. When a significant proportion of enrolled patients drop out before...
Continue reading
MASH (Metabolic dysfunction-associated steatohepatitis) is a chronic liver disease that has gained significant attention from the pharmaceutical industry and cl...
Continue reading
Decentralized and hybrid clinical trials hold significant promise for improving access and reducing patient burden. But implementing them introduces operational...
Continue reading
In this webinar, Patrick Short (Co-Founder and CEO at Sano Genetics) and Will Jones (Co-Founder and CTO at Sano Genetics) discuss the technical challenges of bi...
Continue reading
Recruitment remains one of the most consequential operational challenges in clinical research. This article examines the structural factors that drive enrollmen...
Continue reading